ABECMA- idecabtagene vicleucel suspension
Celgene Corporation
----------
MEDICATION GUIDE
ABECMA® (uh-BEK-muh) (idecabtagene vicleucel) |
---|
This Medication Guide has been approved by the U.S. Food and Drug Administration. Revised: April 2024 |
Read this Medication Guide before you start your ABECMA treatment. The more you know about your treatment, the more active you can be in your care. Talk with your healthcare provider if you have questions about your health condition or treatment. Reading this Medication Guide does not take the place of talking with your healthcare provider about your treatment. |
What is the most important information I should know about ABECMA?
It is important that you tell your healthcare providers that you have received ABECMA and to show them your ABECMA Patient Wallet Card. Your healthcare provider may give you other medicines to treat your side effects. |
What is ABECMA?
|
How will I receive ABECMA?
|
What should I avoid after receiving ABECMA?
|
What are the possible or reasonably likely side effects of ABECMA?
In a study comparing ABECMA to standard regimen, a higher proportion of patients experienced death within the first 9 months from randomization in the ABECMA arm compared to the standard regimens arm. This higher rate of early death was mainly observed before receiving ABECMA with the main reason being progression of multiple myeloma. There was also an increase in the rate of death from adverse events after ABECMA. ABECMA can cause a very common side effect called cytokine release syndrome or CRS, which can be severe or fatal. Symptoms of CRS include fever, difficulty breathing, dizziness or light-headedness, nausea, headache, fast heartbeat, low blood pressure, or fatigue. Tell your healthcare provider right away if you develop fever or any of these other symptoms after receiving ABECMA. ABECMA can increase the risk of life-threatening infections that may lead to death. Tell your healthcare provider right away if you develop fever, chills, or any signs or symptoms of an infection. ABECMA can lower one or more types of your blood cells (red blood cells, white blood cells, or platelets), which may make you feel weak or tired or increase your risk of severe infection or bleeding. After treatment, your healthcare provider will test your blood to check for this. Tell your healthcare provider right away if you get a fever, are feeling tired, or have bruising or bleeding. ABECMA may increase your risk of getting cancers including certain types of blood cancers. Your healthcare provider should monitor you for this. Having ABECMA in your blood may cause a false-positive human immunodeficiency virus (HIV) test result by some commercial tests. These are not all the possible side effects of ABECMA. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. |
General information about the safe and effective use of ABECMA
|